Added to YB: 2023-10-30
Pitch date: 2023-10-30
CPRX:US [bullish]
Catalyst Pharmaceuticals, Inc.
+94.56%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
Market Cap
$2.8B
Pitch Price
$12.14
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.80
P/E
17.61
EV/Sales
4.65
Sector
Biotechnology
Category
N/A
Show full summary:
Catalyst Pharmaceuticals, Inc. CPRX:US
A summary for this pitch has not been created yet.
Read full article (0 min)